Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G de Pinieux

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
British Journal of Clinical Pharmacology|September 1, 1996
Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratioG De Pinieux, P Chariot, M Ammi-Saïd, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|July 15, 2009
[Black bone disease of the skull and facial bones]B Laure, A Petraud, F Sury, et al.
British Journal of Cancer|February 26, 2009
CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenograftsE Marangoni, N Lecomte, L Durand, et al.
Annales De Pathologie|March 3, 1999
[A case of hyalinizing spindle cell tumor with giant rosettes in the presacral region. Immunohistochemical and ultrastructural study]G de Pinieux, P Anract, M le Charpentier, et al.
British Journal of Cancer|February 5, 2004
Mucinous differentiation features associated with hormonal escape in a human prostate cancer xenograftM-E Legrier, G de Pinieux, K Boyé, et al.
Annales De Chirurgie Plastique Et Esthetique|February 6, 2013
[Thigh root reconstruction with a pedicled DIEP flap]A Gourari, R Quignon, F Tabareau-Delalande, et al.
British Journal of Cancer|January 11, 2007
Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanismsM-E Legrier, S Oudard, J-G Judde, et al.
Pathologie-Biologie|March 12, 2003
[A new model of human prostate cancer, the PAC120 xenograft]M E Legrier, G de Pinieux, F Poirson-Bichat, et al.
Oncogene|January 31, 2017
Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cellsG-A Franzetti, K Laud-Duval, W van der Ent, et al.
The American Journal of Pathology|August 4, 2001
Clinical and experimental progression of a new model of human prostate cancer and therapeutic approachG de Pinieux, M E Legrier, F Poirson-Bichat, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
British Journal of Clinical Pharmacology|September 1, 1996
Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratioG De Pinieux, P Chariot, M Ammi-Saïd, et al.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale|July 15, 2009
[Black bone disease of the skull and facial bones]B Laure, A Petraud, F Sury, et al.
British Journal of Cancer|February 26, 2009
CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenograftsE Marangoni, N Lecomte, L Durand, et al.
Annales De Pathologie|March 3, 1999
[A case of hyalinizing spindle cell tumor with giant rosettes in the presacral region. Immunohistochemical and ultrastructural study]G de Pinieux, P Anract, M le Charpentier, et al.
British Journal of Cancer|February 5, 2004
Mucinous differentiation features associated with hormonal escape in a human prostate cancer xenograftM-E Legrier, G de Pinieux, K Boyé, et al.
Annales De Chirurgie Plastique Et Esthetique|February 6, 2013
[Thigh root reconstruction with a pedicled DIEP flap]A Gourari, R Quignon, F Tabareau-Delalande, et al.
British Journal of Cancer|January 11, 2007
Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanismsM-E Legrier, S Oudard, J-G Judde, et al.
Pathologie-Biologie|March 12, 2003
[A new model of human prostate cancer, the PAC120 xenograft]M E Legrier, G de Pinieux, F Poirson-Bichat, et al.
Oncogene|January 31, 2017
Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cellsG-A Franzetti, K Laud-Duval, W van der Ent, et al.
The American Journal of Pathology|August 4, 2001
Clinical and experimental progression of a new model of human prostate cancer and therapeutic approachG de Pinieux, M E Legrier, F Poirson-Bichat, et al.
Pageof 6